GrowHub Ltd shares experienced a dramatic surge in early Nasdaq trading on Monday, June 1, 2026, following the release of a binding term sheet for a reverse merger with EnChem America. The stock climbed approximately 541% to $2.23, after reaching an intraday high of $2.95 on massive volume of roughly 88.5 million shares. The move came after the Singapore-based traceability technology company filed a Form 6-K with the SEC, signaling a major strategic pivot.
Reverse Merger Details
According to the filing, GrowHub has signed a binding term sheet with EnChem America, a U.S. subsidiary of South Korea's EnChem Co Ltd, which develops and manufactures battery electrolyte materials. Under the proposed deal, EnChem would merge into a newly created subsidiary of GrowHub, with the private company emerging as the surviving entity. EnChem America's shareholders would own 85% of the combined company on a fully diluted basis, while existing GrowHub holders would retain 15%. The merger assigns a minimum valuation of $400 million to EnChem America.
The term sheet includes strong protections for the private firm. EnChem can walk away from the deal if GrowHub's volume-weighted average price (VWAP) falls below $4.00 per share at closing. This condition underscores the high bar for completion and reflects the significant premium investors are currently pricing into the stock.
Hurdles and Timelines
The transaction faces numerous regulatory and procedural milestones before it can close. These include finalizing a definitive merger agreement, securing shareholder approval for the issuance of new shares under Nasdaq rules, obtaining Nasdaq's listing approval, completing PCAOB-standard audits for EnChem, and having the SEC declare registration statements effective. Additionally, all current GrowHub directors and senior executives are expected to resign at closing, with EnChem's nominees taking control of the board and management.
GrowHub's timeline is further complicated by a separate compliance issue. On May 26, the company received a notice from Nasdaq indicating it had fallen below the minimum stockholders' equity requirement for continued listing on the Nasdaq Capital Market. GrowHub has until July 10 to submit a plan to regain compliance. The company's 2025 annual report revealed a net loss of $13.4 million and a shareholders' deficit of $2.3 million, with revenue dropping sharply to just $64,574 from $237,014 the prior year.
Market Context
The proposed merger represents a dramatic shift in GrowHub's business focus. The company currently operates a blockchain-based supply-chain traceability and authenticity platform, while EnChem specializes in battery electrolyte materials, a critical component in rechargeable batteries. The deal comes amid a broader push by Korean battery materials companies to capture market share in the U.S., as Chinese players face supply chain restrictions. EnChem CEO Oh Jung-Kang noted in a 2024 interview that Chinese competitors are "cut off from the American supply chain," creating a "window of opportunity for Korean companies."
Investors are weighing the potential upside of the merger against significant dilution risks. If the deal proceeds, current GrowHub shareholders will see their ownership stake reduced to just 15%. Moreover, the stock's recent surge may be short-lived if the transaction fails to meet the $4.00 VWAP condition or other regulatory requirements. The next few weeks will be critical as the company works to address its Nasdaq compliance issue and advance the merger.
